Pricing Log in Create free account

Altimmune, Inc. (ALT) vs Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY)

Altimmune, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are both Biotechnology companies. Altimmune, Inc. and Ceryvyn Therapeutics Ltd. - Unsponsored ADR are of similar size ($524.8M and $507.7M). Altimmune, Inc. has the higher net margin (0.00% vs −89,724.2%) and the lower return on invested capital (−34.3% vs 0.00%). Across the 14 metrics below, Ceryvyn Therapeutics Ltd. - Unsponsored ADR leads on 9 and Altimmune, Inc. on 5.

Valuation

Metric ALT CYVNY Biotechnology median
P/E n/m n/m 8.56
P/S 10,320.35 2.37 10.17
P/B 1.00 n/m 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 3,985.41 759.28 9.64
Earnings yield (30.47%) (2,375.00%) (29.41%)
Free cash flow yield (16.17%) (84,379.36%) (23.50%)

Profitability

Metric ALT CYVNY Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (89,724.18%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (28.87%) 0.00% (56.66%)
Return on assets (25.58%) 0.00% (49.22%)
Return on invested capital (34.30%) 0.00% 0.00%

Growth

Metric ALT CYVNY Biotechnology median
Revenue growth (TTM) 130.00% — 5.64%
EPS growth (last fiscal year) 25.37% 61.59% 30.08%
Revenue growth, 5-year CAGR (65.33%) (15.81%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALT CYVNY Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 26.78 0.22 4.72
Net debt to EBITDA 2.49 0.31 0.96

Dividend

Metric ALT CYVNY Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ALT CYVNY Biotechnology median
Market cap 507.69m 524.83m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack